Loading…
avatar for Sarah Pope Miksinski

Sarah Pope Miksinski

FDA
Dir., Off. of New Drug Products; Dir. (Acting), Off. of Surveillance, OPQ, CDER
Dr. Miksinski received her B.A. from Earlham College (1994) and her Ph.D. from Oklahoma State University (1999). She served as an NIH postdoctoral fellow from 2000-2002, and began as a CMC reviewer at the FDA in 2002. She is now the Acting Director of ONDQA/DNDQA 2.